Skip to search formSkip to main content

OSLER-RENDU-WEBER SYNDROME 2

Known as: HHT2, Telangiectasia, hereditary hemorrhagic, type 2 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
To describe clinical presentations of hereditary hemorrhagic telangiectasia (HHT) patients in Japan. There were 80 patients (40… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 3
Is this relevant?
2014
2014
Activin A receptor, type II-like kinase 1 (ALK1 is a serine-threonine kinase) predominantly expressed on endothelial cells… Expand
  • figure 1
Is this relevant?
2012
2012
Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disease characterised by vascular dysplasia and increased… Expand
  • figure 1
  • figure 6
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Hereditary hemorrhagic telangiectasia (HHT) is a genetically heterogeneous vascular dysplasia with multiple telangiectases and… Expand
Is this relevant?
2006
2006
To the Editor: The identification of underlying causal genes in familial forms of cerebrovascular malformations allows the… Expand
Is this relevant?
2003
2003
BACKGROUND Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant vascular dysplasia characterised by… Expand
  • table 2
  • table 1
  • table 3
  • figure 1
  • table 4
Is this relevant?
1996
1996
Hereditary haemorrhagic telangiectasia (HHT) is a genetically heterogeneous dominant disorder. Two disease loci have been mapped… Expand
  • figure 1
  • figure 2
Is this relevant?